It is less than 3% of last year’s net profit which is fine. Plus for a 2000cr pharma company that is growing well, the salary seems par.
Subscribe To Our Free Newsletter |
It is less than 3% of last year’s net profit which is fine. Plus for a 2000cr pharma company that is growing well, the salary seems par.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!